Dr. John H. Strickler is a medical oncologist at Mayo Clinic in Florida who specializes in gastrointestinal cancers, including pancreatic, gastroesophageal and colorectal cancers. His professional work combines cancer treatment with clinical investigation, particularly research intended to improve treatment options for people with complex gastrointestinal malignancies. Mayo Clinic's official biography notes that he previously spent 15 years at Duke University, where he held academic and leadership roles in precision cancer medicine and gastrointestinal oncology research.

Expertise in gastrointestinal oncology

Gastrointestinal oncology covers cancers affecting organs of the digestive system, including the esophagus, stomach, pancreas, colon and rectum. These conditions differ in their biology, symptoms, staging and treatment options. A medical oncologist helps evaluate the diagnosis and determine whether treatment may involve chemotherapy, targeted medicines, immunotherapy or a combination of approaches, depending on the cancer type and its characteristics.

The treatment plan is influenced by biopsy results, imaging, disease stage, previous therapies, overall health and patient preferences. In selected cases, molecular or genetic testing of the tumor can help identify treatment options. Testing is not equally informative for every cancer, so the oncology team determines which investigations are appropriate.

Pancreatic cancer care

Pancreatic cancer can require coordinated input from medical oncology, surgical oncology, radiology, pathology and other specialists. Evaluation commonly includes confirmation of the diagnosis, imaging to assess the extent of disease and review of whether surgery or systemic treatment may be appropriate.

Treatment depends on factors such as tumor location, whether the disease has spread and the patient's ability to tolerate therapy. Some patients may be evaluated for surgery alongside additional treatment, while others may be advised to consider systemic therapy or clinical trials. No single approach is suitable for every patient.

Patients seeking a second opinion should provide pathology reports, imaging, operative notes if applicable, previous treatment details and a current medication list. Having the original scan files as well as written reports can help the clinical team assess the case more efficiently.

Colorectal and gastroesophageal cancers

Colorectal cancers arise in the colon or rectum, while gastroesophageal cancers affect the esophagus, stomach or related junctional areas. Treatment pathways depend on the exact diagnosis and stage. A multidisciplinary team may consider surgery, chemotherapy, radiation therapy, targeted treatment or immunotherapy when appropriate.

For advanced disease, oncologists may review tumor biomarkers and prior treatment response when selecting subsequent therapies. Patients should ask their care team to explain the expected benefits, possible side effects, alternatives and goals of each proposed treatment. These discussions are particularly important when comparing treatment options across countries.

Precision medicine and clinical research

Dr. Strickler's professional biography identifies leadership in gastrointestinal oncology and clinical cancer research. It also describes his work in precision cancer medicine and his role in clinical trials, including research involving targeted treatment for a molecularly defined group of colorectal cancer patients.

Precision oncology uses information about a tumor's characteristics to help guide treatment decisions. Depending on the cancer, this may include molecular profiling, biomarkers or other diagnostic findings. A test result does not automatically mean a particular therapy will be effective; the clinical significance must be interpreted in the context of the patient's diagnosis and available evidence.

Clinical trials can offer access to investigational approaches for eligible patients, but they have specific inclusion criteria and may involve additional visits or risks. Patients should ask whether a trial is open, whether international patients can participate and whether the study requires treatment at the hospital for an extended period.

Coordinated cancer treatment

Complex cancer care often requires collaboration among medical oncologists, surgeons, radiation oncologists, radiologists, pathologists and supportive-care professionals. The aim is to coordinate decisions and align treatment with the diagnosis, evidence and patient's goals.

Patients may also need support managing treatment-related symptoms, nutrition, emotional stress and practical issues associated with long-term care. The appropriate support services depend on the individual treatment plan.

Guidance for international patients

Before travelling, request an assessment of the case and a written treatment proposal where available. Confirm the expected schedule, likely length of stay, cost estimates, medication access, follow-up requirements and whether any proposed treatment can be continued in the patient's home country.

A medical tourism listing should describe Dr. Strickler's documented areas of practice without guaranteeing access to a specific therapy or outcome. Final treatment recommendations must follow a full clinical evaluation.